Cartesian Therapeutics
RNAC
RNAC
57 hedge funds and large institutions have $144M invested in Cartesian Therapeutics in 2018 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 31 increasing their positions, 8 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 59 → 57 (-2)
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
Holders
57
Holding in Top 10
1
Calls
$44K
Puts
$7K
Top Buyers
| 1 | +$6.05M | |
| 2 | +$4.97M | |
| 3 | +$3.37M | |
| 4 |
Millennium Management
New York
|
+$1.58M |
| 5 |
Man Group
London,
United Kingdom
|
+$1.43M |
Top Sellers
| 1 | -$6.05M | |
| 2 | -$4.49M | |
| 3 | -$1.85M | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$548K |
| 5 |
Allianz Asset Management
Munich,
Germany
|
-$495K |